B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

0.3722 -0.0368 (-9.00%)
Streaming Delayed Price Updated: 3:46 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,438,515
Open 0.3600
Bid (Size) 0.3699 (800)
Ask (Size) 0.3745 (2,000)
Prev. Close 0.4090
Today's Range 0.3400 - 0.3750
52wk Range 0.2907 - 14.14
Shares Outstanding 910,688
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's pre-market session ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill

Performance

YTD
-90.4%
-90.4%
1 Month
+2.3%
+2.3%
3 Month
-52.3%
-52.3%
6 Month
-90.2%
-90.2%
1 Year
-95.3%
-95.3%

More News

Read More
News headline image
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
From Glucotrack, Inc.
Via GlobeNewswire
Top movers in Thursday's after hours session ↗
Via Chartmill
News headline image
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
From Glucotrack, Inc.
Via GlobeNewswire
Wednesday's session: most active stocks ↗
Via Chartmill
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
From Glucotrack, Inc.
Via GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
News headline image
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
What's going on in today's session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is GlucoTrack, Inc. - Common Stock publicly traded?
Yes, GlucoTrack, Inc. - Common Stock is publicly traded.
What exchange does GlucoTrack, Inc. - Common Stock trade on?
GlucoTrack, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GlucoTrack, Inc. - Common Stock?
The ticker symbol for GlucoTrack, Inc. - Common Stock is GCTK on the Nasdaq Stock Market
What is the current price of GlucoTrack, Inc. - Common Stock?
The current price of GlucoTrack, Inc. - Common Stock is 0.3722
When was GlucoTrack, Inc. - Common Stock last traded?
The last trade of GlucoTrack, Inc. - Common Stock was at 07/21/26 03:46 PM ET
What is the market capitalization of GlucoTrack, Inc. - Common Stock?
The market capitalization of GlucoTrack, Inc. - Common Stock is 338.96K
How many shares of GlucoTrack, Inc. - Common Stock are outstanding?
GlucoTrack, Inc. - Common Stock has 339K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.